The iShares MSCI Pacific Ex. Japan ETF (EPP) invests in over 90 companies in developed Pacific markets, excluding Japan, with a 0.48% management fee. This ETF offers a 3.7% dividend yield and lower valuation, making it a safer option against potential sell-offs in growth and tech stocks in 2025-2026. The ETF primarily tracks the MSCI Pacific Ex. Japan Index, heavily weighted in banking, materials, and industrials, which constitute over 60% of the index.
WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced positive feedback from its Type C meeting with the U.S. Food and Drug Administration (FDA) to discuss the APOLLO post-marketing confirmatory trial for bitopertin in EPP.
WATERTOWN, Mass., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, will host a conference call to discuss feedback received from its Type C meeting on bitopertin in EPP with the U.S. Food and Drug Administration (FDA). The conference call will be held on Tuesday, January 21, at 8:00 am EST.
![]() EPP 11 months ago Paid | Semi Annual | $0.7 Per Share |
![]() EPP 20 Dec 2023 Paid | Semi Annual | $0.97 Per Share |
![]() EPP 7 Jun 2023 Paid | Semi Annual | $0.81 Per Share |
![]() EPP 13 Dec 2022 Paid | Semi Annual | $0.71 Per Share |
![]() EPP 9 Jun 2022 Paid | Semi Annual | $1.16 Per Share |
![]() EPP 11 months ago Paid | Semi Annual | $0.7 Per Share |
![]() EPP 20 Dec 2023 Paid | Semi Annual | $0.97 Per Share |
![]() EPP 7 Jun 2023 Paid | Semi Annual | $0.81 Per Share |
![]() EPP 13 Dec 2022 Paid | Semi Annual | $0.71 Per Share |
![]() EPP 9 Jun 2022 Paid | Semi Annual | $1.16 Per Share |
ARCA Exchange | US Country |
The described fund is an investment vehicle that primarily focuses on allocating its assets within the equities of companies located in four specific countries or regions: Australia, Hong Kong, New Zealand, and Singapore. By adhering to a strategy that involves investing at least 80% of its assets in the securities making up its underlying index or in investments closely paralleling the economic characteristics of such securities, the fund aims to mimic the performance of its benchmark index. This index comprises large- and mid-capitalization companies, which represent a significant portion of the stock market's value within these countries or regions. It's important to note that the composition of the underlying index may evolve over time to accommodate market changes. Despite its broad geographical coverage, the fund qualifies as non-diversified, concentrating its investments more heavily in fewer securities than a diversified fund might.
The core product offering involves the direct investment in the component securities that form the basis of the fund's underlying index. This approach ensures that the fund's performance closely tracks that of the index, reflecting the economic landscape of Australia, Hong Kong, New Zealand, and Singapore.
Aside from traditional direct investment in component securities, the fund also allocates assets to investments that have economic characteristics nearly identical to those of the index's securities. This strategy allows the fund to maintain its targeted exposure and performance objectives even when direct investment in a component security might not be possible or optimal.
The investment philosophy prioritizes large- and mid-cap companies within the underlying index. This focus reflects a belief in the stability and growth potential of well-established businesses, which typically have a significant market presence in their respective countries or regions.